Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
about
Adhesion molecules in CNS disorders: biomarker and therapeutic targetsVascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetesCytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularizationAtrial natriuretic peptide reduces vascular leakage and choroidal neovascularizationParstatin suppresses ocular neovascularization and inflammation.Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit modelLocalization of vascular adhesion protein-1 (VAP-1) in the human eye.Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344Targeting of junctional adhesion molecule-C inhibits experimental choroidal neovascularizationBlockade of vascular adhesion protein-1 attenuates choroidal neovascularization.The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis.Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.Vascular adhesion protein 1 in the eye.Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread.Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.Ocular neovascularization.Semicarbazide-sensitive amine oxidase and kidney disease.Ectoenzymes in leukocyte migration and their therapeutic potential.Vascular adhesion protein-1: Role in human pathology and application as a biomarker.Leukocyte adhesion molecules in diabetic retinopathy.Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy.Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.Differential proteomic analysis of white adipose tissues from T2D KKAy mice by LC-ESI-QTOF.Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
P2860
Q27015967-5A1EEEDC-B320-43E9-8F4E-A4325A98E9CEQ28576300-3ED65D89-FD11-46F8-B503-98FF33C8EC73Q30583016-250833FC-9F7E-4CFA-9BD4-541634E6A9FAQ30884052-0D511441-E621-4625-884B-7277295270D1Q33600912-6BA70CC2-BD0F-4C84-A5F6-30DBD0B0CA6DQ33668275-5559C99B-20DB-430E-B536-76CA1AC67334Q33677290-EA262BF2-3AC8-4413-915A-111D8881ABBAQ33832464-A372A865-48F6-4F20-9BAB-CCD00AB2ABDFQ33944710-C581766E-F0D2-41E3-AF89-99EC868500C4Q33999514-F81455C8-DBE0-43F8-9858-E7050A73D8C6Q34113663-06A0E20B-DF44-4FB3-9BE3-DDD8EC58B37FQ34155901-9EC0FC4B-3DEB-4E0D-8207-2C615F57B30CQ34196720-6432959E-6EA8-4B86-A2CE-683D78BF3766Q34276196-39489DD0-B5C4-4DEA-BFC1-B7AD9B7FAD5AQ34714731-D5235585-739D-45B3-B212-4FCD38AF6383Q34805413-675BB4D2-F1D9-42FE-AF27-2B0985FDE2EDQ36083881-6651A7E2-A893-45F3-A1F9-32DB5745DF16Q36942812-EF51320C-9D8C-41B1-A0EE-C02457C96997Q37330522-7B75F6CD-8D92-4333-9EC7-F6E5431675C0Q37792817-6CA39AF7-65D9-4768-BAF3-FE6AAADBE6DDQ37868326-6417F55B-7FDB-4ED1-BA21-B6F45ADA685AQ37889987-D92B6158-60DC-4073-AA81-9C7AD7297478Q38074872-5AB090A7-21FC-45F9-B7F3-F82845B3ECC1Q38156644-C64B3C4C-53C1-4638-B10A-777FD16FB05BQ38196724-ACC90D40-031A-4DCB-BE41-4FD411A84A86Q38569377-C9557776-CADB-464C-9A1B-0C50BD2CECDBQ39111812-DD268A67-15C8-4925-AF7F-0046258C7DD6Q44230745-DEE42C80-0968-4334-AE5F-B206207FB3FAQ46372230-E4E4F38F-087C-413E-8CF6-4D952F0D0231Q50069408-05ADA338-90BF-422E-A13E-0AEB0859FCB3Q50106596-16CB4FA8-9FF9-4125-8E84-1EF4305241A0Q55343968-839D011E-DF28-4700-B4A8-1579F1A3C2F8
P2860
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@ast
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@en
type
label
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@ast
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@en
prefLabel
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@ast
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.
@en
P2093
P2860
P50
P356
P1433
P1476
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization
@en
P2093
Evangelos S Gragoudas
Haicheng She
Kennard L Thomas
Kousuke Noda
Lama Almulki
Rebecca C Garland
Shinsuke Miyahara
Shintaro Nakao
Souska Zandi
Toru Nakazawa
P2860
P304
P356
10.1096/FJ.07-105346
P407
P577
2008-04-24T00:00:00Z